11Nov
COVID-19 Report for Life Sciences and Health Care Companies (UPDATED)
In Tuesday's Report: the expanding role of real-world evidence in FDA medical device submissions; President-elect Joe Biden lays out COVID-19 plan; Pfizer announces vaccine efficacy; and an analysis of material adverse change (MAC) clauses in Japan....
By:
Hogan Lovells
Related
The Singapore government has introduced additional control measures to minimize the risk of further ...
Read More >
A parent can use intermittent Family and Medical Leave to attend an individualized education program...
Read More >
The 359-page emergency Coronavirus Bill received royal assent on 25 March 2020. This newly passed Co...
Read More >
The global pandemic has wreaked havoc on businesses from a wide variety of industries (e.g., life sc...
Read More >
What is privilege? Privilege is a well-known right entitling a person who is involved in legal proc...
Read More >
In the wee hours of December 2019, Congress revived the PCORI fee and filing obligations of employer...
Read More >